VN

Varsha Nikhilgiri Goswami

Active Director Designated Partner DIN 10037368
DIN 10037368 First appointment Jan 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Varsha Nikhilgiri Goswami

Data last updated:

Varsha Nikhilgiri Goswami is a Designated Partner at Vonartes Pharmaceutical Llp (since 2023). The company operates in Pharma.

DIN 10037368
Primary Designation Designated Partner
Industry Pharma
First Appointment 04 Jan 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner04 Jan 20232023Active

Board colleagues of Varsha Nikhilgiri Goswami

NameDINCompanyDesignation
Vinodbhai Shivrambhai Patel05139893Vonartes Pharmaceutical LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Vonartes Pharmaceutical Llp
Premium access

Shareholding and investment profile for Varsha Nikhilgiri Goswami

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Varsha Nikhilgiri Goswami

Varsha Nikhilgiri Goswami currently holds 1 directorship: Vonartes Pharmaceutical Llp (Designated Partner, since 04 Jan 2023).

Varsha Nikhilgiri Goswami was first appointed on 04 Jan 2023 as Designated Partner at Vonartes Pharmaceutical Llp.

The current boards of Varsha Nikhilgiri Goswami's companies include Vinodbhai Shivrambhai Patel (Vonartes Pharmaceutical Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available